Order Article Reprints

Dotsu Y, Yamaguchi H, Fukuda M, Suyama T, Honda N, Umeyama Y, Taniguchi H, Gyotoku H, Takemoto S, Tagawa R, et al. Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor. Journal of Clinical Medicine. 2021; 10(18):4221. https://doi.org/10.3390/jcm10184221

Dotsu, Yosuke, Hiroyuki Yamaguchi, Minoru Fukuda, Takayuki Suyama, Noritaka Honda, Yasuhiro Umeyama, Hirokazu Taniguchi, Hiroshi Gyotoku, Shinnosuke Takemoto, Ryuta Tagawa, and et al. 2021. "Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor" Journal of Clinical Medicine 10, no. 18: 4221. https://doi.org/10.3390/jcm10184221

Dotsu, Y., Yamaguchi, H., Fukuda, M., Suyama, T., Honda, N., Umeyama, Y., Taniguchi, H., Gyotoku, H., Takemoto, S., Tagawa, R., Ogata, R., Tomono, H., Shimada, M., Senju, H., Nakatomi, K., Nagashima, S., Soda, H., Ikeda, H., Ashizawa, K., & Mukae, H. (2021). Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor. Journal of Clinical Medicine, 10(18), 4221. https://doi.org/10.3390/jcm10184221